The economic, psychosocial burden and State ownership of HIV/AIDS Programme in Nasarawa State, Nigeria
Main Article Content
Abstract
Background: Nasarawa State has a high HIV prevalence rate of 7.5%. This may adversely affect the socio-conomic and psychological wellbeing of people living with HIV.
Objectives: This study sought to examine the economic and psychosocial burden of HIV on infected people and assess the preparedness of the State government towards HIV/AIDS ownership and sustainability.
Method: The study design is descriptive cross-sectional survey involving 312 respondents' randomly selected from 6 hospitals following a two stage stratified sampling across the State.
Results: Respondents' with the lowest discretional income 41 (44.6%) p-values 0.006 and those with the lowest educational status 24 (55.8%) p-values 0.032 were significantly associated with higher CD4 counts (≥3350cells/mm ). Statistical association exists between stigmatizing attitudes and ART adherence; respondents' who rejected stigmatizing attitudes, stereotypes and negative perceptions ascribed to them by the society recorded significant difference in adherence to medication 92 (98.9%), p-value 0.000; 57 (100%) p-value 0.016; 91 (96.8%) p-value 0.009; and 80 (97.6%) with p-value 0.024. Laboratory parameters indicated that packed cell volume, haemoglobin and CD4 values before HAART and pre-data collection were below normal values. A Chi-square test indicated significant difference between the State owned drug revolving fund and the assisted 22 (donor-funded) ART scheme; X = 152.66, Critical X = 11.07.
Conclusion: Respondents' with strong coping mechanism rejected the stigmatizing attributes ascribed to them thereby achieving the recommended level of adherence; poor socio-economic groups recorded better treatment outcomes. This study revealed that the State has not shown significant commitment toward the sustainable provision of HIV/AIDS scheme.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
Share
References
Kassutto S, Maqhsoudi K, Johnson MN, Robbins G B, Burqett NC, Sar PE, Cohen D, Pae E, Davis B, Zachary K, Basqoz N, D'aqata EM, De-Gruttola V, Walker BD, and Rosenberg, ES (2006). Longitudinal Analysis of Clinical Markers Following Antiretroviral Therapy Initiated During Acute or Early HIV-Type 1 Infection. Clin. Infect. Dis. 42: 1024-1031. Cited at: www.ncbi.nil.nih.gov/pubmed/16511771.Access
ed: 09/08/2011.
Weitz R (2004). The sociology of health, illness and Healthcare. A critical approach. 3rd ed. USA: Thomson Wadsworth publishing:
-143, 174-176.
WHO (2011). Global HIV/AIDS response: epidemic update and health sector progress toward universal access. Available at:
www. who.int/hiv/pub/progressreport 2011/en
UNAIDS (2008). Reports on the global AIDS epidemic. Geneva; UNAIDS publications: 16, 76- 77, 89.
Ogwuche OC (2009). Women and problem of HIV/AIDS pandemic seeking redress through education. Benue Journal of Gender Studies.
:273.
Green D (2008). From Poverty to Power. How Active Citizens and Effective States can Change the World. UK: Oxfam publications: 5-8, 27, 111.
UNAIDS (2007). Reducing HIV stigma and discrimination: A critical part of National AIDS programmes. A resource for national stakeholders
in the HIV response: 9. Available at: www.unaids.org/en/media/unaids/contentsasset s/data/import/pub/report/2008/j1521-stigmatization-en-pdf. Accessed: 8/8/2011.
Kombol MA (2007). Significance of Inter-Ethnic Perception and Stereotypes among Selected Ethnic Groups in Nigeria: A Survey of Derogatory Words. African Journal of Indigenous Development. 3 (1 & 2): 101-107.
WHO (2008). World Health Statistics. France: 14.
Federal Ministry of Health Technical Report (2010). National HIV Sero-Prevalence Sentinel Survey 2010: Abuja
WHO (1993). How to investigate drug use in health facilities: selected drug use indicators. Geneva:23.
Adeokun L, Okonkwo P and Oladapo AL (2006). The stigmatization of people living with HIV/AIDS. In: Adeyi O, Kanki PJ, Odutolu O and Idoko JA. AIDS in 135 West African Journal of Pharmacy (2014) 25 (2) Nigeria: a nation on the threshold. Cambridge, Harvard University Press: 213-231.
Armstrong J (1995). Uganda's AIDS Crisis: Its Implications for development. World Bank Discussion Paper: 39, 47, 54
Bollinger L, Stover J and Nwaorgu O (1999). The economic impact of AIDS in Nigeria. The Policy Project 1-5Cited in: www.policyproject.com/pub/SEimpact/Nigeria.pdf Accessed: 19/08/2011
Federal Ministry of Health Technical Report (2003). National HIV Sero-Prevalence Sentinel Survey 2003: Abuja
Blackburn C (1991).Poverty and Health: Working with Families. Buckingham: Open University Press.
Adanu RMK, Hill AG, Seffah JD, Darko R, Anarfi JK and Duda RB (2008). Sexual transmitted Infections and health seeking behaviour among Ghanaian women in Accra. African Journal of Reproductive Health 12(3): 152 - 157
Shavadia J, Tesfaldet G and Twahir M, (2009). Antiretroviral therapy Dose Adjustment Based on Calculated Creatine Clearance. East African
Medical Journal 86(1): 186-188
De Waal A, Kiot JF, Mahajan M and Huber D (2009). HIV/AIDS, Security and Conflicts: New Realities, New responses: 63 – 64. Cited at: www.ssr.org/workspace/images/crm/newpublica tion31%7BE2090d2b-72a8-de11-9d32- 001ccec70%7d.pdf Accessed 8/8/2011
Ityavyar D (2004). The Family and Gender Violence in Contemporary Nigeria. Journal of Family Development. 1(1): 1 – 15
Batten SR and Upchurch M (2010). Psychoneuroimmunology: An analysis of HIV/AIDS and Cancer. Undergraduate Research Journal for
the Human Sciences. 9 : 1 – 9 Cited at www.kon.org/urc/v9/batten.htm Accessed: 02/08/2012
International Treatment Preparedness Coalition (ITPC) (2007). Missing the target No5: Improving AIDS drug access and advancing health care for all. In: UNAIDS (2008). Report on the global AIDS epidemic: 152
Davis F (1961). Deviance disavowal: Management of strained interaction by the visibly handicapped. Social Problems 9:120-132.
Lazarus RS (1991). Progress on a Cognitive Motivational–Relational Theory of Emotion. American Psychologists. 46: 819 – 834
Fife BL, and Wright ER (2000). Dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health and Soc Behaviour; 41(1): 50-67.
Sambo MN, Lewis I and Sabitu K (2008). Essential Drugs in Primary Health Centres of North Central Nigeria: Where is Bamako Initiative? Nigerian 136 West African Journal of Pharmacy (2014) 25 (2) Journal of Clinical Practice. 11(1): 9 – 13.
Uzochukwu BSC, Onwujekwe OE and Akpala CO (2002). Effects of Bamako – Initiative Drug Revolving Fund on Availability and Rational use of Essential Drugs in Primary Healthcare Facilities in South-East, Nigeria. Journal of Health Policy and Planning. 17(4): 378 – 383